pros and cons of tirzepatide Day 3: Mounjaro (Tirzepatide – weekly injection) Class: Dual GLP-1 GIP receptor agonist Avg Weight Loss: ~20% baseline weight (SURMOUNT-1 trial) FDA Status: Approved for type 2 diabetes; Fast-tracked for What Is Zepbound (tirzepatide)? Uses,
Pay in 4 interest-free payments of $6.76 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

























